BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18828769)

  • 1. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.
    Bluestone JA; Liu W; Yabu JM; Laszik ZG; Putnam A; Belingheri M; Gross DM; Townsend RM; Vincenti F
    Am J Transplant; 2008 Oct; 8(10):2086-96. PubMed ID: 18828769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation.
    Wang Z; Shi BY; Qian YY; Cai M; Wang Q
    Clin Exp Immunol; 2009 Mar; 155(3):496-503. PubMed ID: 19141125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulatory T cells in kidney transplant recipients].
    Libetta C; Portalupi V; Margiotta E; Sepe V; Canevari M; Meloni F; Morosini M; Dal Canton A
    G Ital Nefrol; 2009; 26 Suppl 45():S54-7. PubMed ID: 19382095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.
    Chavez H; Beaudreuil S; Abbed K; Taoufic Y; Kriaa F; Charpentier B; Durrbach A
    Transpl Immunol; 2007 Jun; 17(4):243-8. PubMed ID: 17493526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD25 appears non essential for human peripheral T(reg) maintenance in vivo.
    de Goër de Herve MG; Gonzales E; Hendel-Chavez H; Décline JL; Mourier O; Abbed K; Jacquemin E; Taoufik Y
    PLoS One; 2010 Jul; 5(7):e11784. PubMed ID: 20689592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation.
    Vondran FW; Timrott K; Tross J; Kollrich S; Schwarz A; Lehner F; Klempnauer J; Becker T; Schwinzer R
    Transpl Int; 2010 May; 23(5):514-23. PubMed ID: 19951265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen.
    Thibault G; Paintaud G; Legendre C; Merville P; Coulon M; Chasseuil E; Ternant D; Rostaing L; Durrbach A; Di Giambattista F; Büchler M; Lebranchu Y
    Transpl Int; 2016 Feb; 29(2):184-95. PubMed ID: 26369526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.
    Grimbert P; Audard V; Diet C; Matignon M; Plonquet A; Mansour H; Desvaux D; Durrbach A; Cohen JL; Lang P
    Nephrol Dial Transplant; 2011 Mar; 26(3):1087-93. PubMed ID: 20667993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation.
    López-Abente J; Martínez-Bonet M; Bernaldo-de-Quirós E; Camino M; Gil N; Panadero E; Gil-Jaurena JM; Clemente M; Urschel S; West L; Pion M; Correa-Rocha R
    Sci Rep; 2021 Jan; 11(1):827. PubMed ID: 33436905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A.
    Furuzawa-Carballeda J; Lima G; Alberú J; Palafox D; Uribe-Uribe N; Morales-Buenrostro LE; Reyes Acevedo R; Mondragón G; Chevaile A; Llorente L
    Clin Exp Immunol; 2012 Feb; 167(2):330-7. PubMed ID: 22236010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
    Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
    Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
    Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
    Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment.
    Furuzawa-Carballeda J; Lima G; Uribe-Uribe N; Avila-Casado C; Mancilla E; Morales-Buenrostro LE; Pérez-Garrido J; Pérez M; Cárdenas G; Llorente L; Alberú J
    Transplant Proc; 2010 Nov; 42(9):3489-96. PubMed ID: 21094802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H.
    Bloom DD; Chang Z; Fechner JH; Dar W; Polster SP; Pascual J; Turka LA; Knechtle SJ
    Am J Transplant; 2008 Apr; 8(4):793-802. PubMed ID: 18261176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
    Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
    Front Immunol; 2021; 12():716559. PubMed ID: 34335631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report.
    Zhao T; Yang C; Xue Y; Qiu YY; Hu L; Qiu Y; Wang X; Yang B; Rong R; Xu M; Zhu T
    Transplant Proc; 2012 Jan; 44(1):175-8. PubMed ID: 22310608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Belatacept.
    Vincenti F; Dritselis A; Kirkpatrick P
    Nat Rev Drug Discov; 2011 Aug; 10(9):655-6. PubMed ID: 21878974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.